# Probiotics and immunity: provisional role for personalized diets and disease prevention

**Authors:** Rostyslav V. Bubnov, Mykola Ya Spivak, Liudmyla M. Lazarenko, Alojz Bomba, Nadiya V. Boyko

PMC · DOI: 10.1186/s13167-015-0036-0 · The EPMA Journal · 2015-07-14

## TL;DR

This paper reviews how probiotics may support immunity and disease prevention through personalized diets and new medical technologies.

## Contribution

The paper proposes novel applications of probiotics in personalized medicine and highlights emerging technologies for their use.

## Key findings

- Probiotics may influence the gut-brain axis and help manage immune and inflammatory conditions.
- Bacterial wall elasticity could predict immune responses, guiding personalized probiotic use.
- Advanced imaging and nanobiotech may enhance future probiotic-based treatments.

## Abstract

There is great interest in the interaction between diet and immune system and concomitantly in the potential of probiotic bacteria, especially given recent advances in understanding of gut microbiota effects on health in the context of microbiome research. Following our recent study on bacterial wall elasticity as a predictive measure of phagocytic cellular reactions and related outcomes, a question was raised regarding the scope of the application of these findings in various medical conditions in the context of predictive, preventive, and personalized medicine (PPPM). This summarizing review of the data describes the contributions, both observed and potential, of probiotics to the gut-brain axis and various medical conditions, including immune and atopic states, metabolic and inflammatory diseases—including liver disease and diabetes mellitus—cancer, and more. It also suggests novel insights for a number of beneficial applications of probiotics and advances in development of novel probiotic-based treatments and personalized diets, as well as application of sophisticated imaging techniques and nanobiotechnologies that can be adopted in the near future by innovative medical experts, warranting further research and practical translation.

## Linked entities

- **Diseases:** liver disease (MONDO:0005154), diabetes mellitus (MONDO:0005015), cancer (MONDO:0004992)

## Full-text entities

- **Genes:** UCP1 (uncoupling protein 1) [NCBI Gene 7350] {aka SLC25A7, UCP}, Il9 (interleukin 9) [NCBI Gene 16198] {aka Il-9, P40}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, TPH1 (tryptophan hydroxylase 1) [NCBI Gene 7166] {aka TPRH, TRPH}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Hand2 (heart and neural crest derivatives expressed 2) [NCBI Gene 15111] {aka Ehand2, Hed, Th2, Thing2, bHLHa26, dHAND}, Adora2b (adenosine A2b receptor) [NCBI Gene 11541] {aka A2BAR, A2BR, A2b, AA2BR, ARA2B}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867] {aka FFA2R, GPR43}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, Serpinb1-ps1 (serine (or cysteine) peptidase inhibitor, clade B, member 1, pseudogene) [NCBI Gene 282665] {aka EID, ovalbumin}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Muc4 (mucin 4) [NCBI Gene 140474] {aka 4933405I11Rik, Asgp}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, Muc6 (mucin 6, gastric) [NCBI Gene 353328], Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, ANG (angiogenin) [NCBI Gene 283] {aka ALS9, HEL168, RAA1, RNASE4, RNASE5}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}
- **Diseases:** COPD (MESH:D029424), hepatobiliary disease (MESH:D004066), liver fibrosis (MESH:D008103), diseases of musculoskeletal system (MESH:D009140), diabetes (MESH:D003920), premature death (MESH:D003643), hypertension (MESH:D006973), myocarditis (MESH:D009205), CVD (MESH:D002318), acute coronary syndromes (MESH:D054058), breast cancer (MESH:D001943), bacterial (MESH:D001424), neutrophilia (MESH:C563010), hypercholesterolemia (MESH:D006937), airway obstruction (MESH:D000402), inflammatory vessel diseases (MESH:C536223), chronic cholecystitis (MESH:D002764), NAFLD (MESH:D065626), immune-microbial dysfunction (MESH:D007154), pulmonary inflammatory (MESH:D016726), mastocytosis (MESH:D008415), insulin-dependent diabetes (MESH:D003922), clinical disorders (MESH:D000075902), RA (MESH:D001172), anxiety (MESH:D001007), sleep disorders (MESH:D012893), stroke (MESH:D020521), Cholestasis (MESH:D002779), bacterial vaginosis (MESH:D016585), Flammer syndrome (MESH:D013577), depression (MESH:D003866), parasitic worm ( (MESH:D010272), APUD (MESH:C536778), lung cancer (MESH:D008175), fibrosis (MESH:D005355), Vasospasm (MESH:D020301), ischemia (MESH:D007511), sepsis (MESH:D018805), metabolic and inflammatory diseases (MESH:D008659), infants (MESH:D063766), irritable bowel syndrome (MESH:D043183), Asthma (MESH:D001249), viral infections (MESH:D014777), pulmonary eosinophilia (MESH:D011657), liver disease (MESH:D008107), neurologic disease (MESH:D020271), vascular remodelling (MESH:D066253), musculoskeletal, respiratory, metabolic syndrome (MESH:D009139), cancer (MESH:D009369), osteochondrosis (MESH:D055034), allergic airway diseases (MESH:D004342), reperfusion injury (MESH:D015427), dysbiosis (MESH:D064806), helminth infections (MESH:D007239), C. difficile infection (MESH:D003015), pulmonary lymphocytosis (MESH:D008218), -related diseases (MESH:D000077733), arthritis (MESH:D001168), IBD (MESH:D015212), Pain (MESH:D010146)
- **Chemicals:** peroxynitrite (MESH:D030421), ethane (MESH:D004980), biopolymers (MESH:D001704), CeO2 (MESH:C030583), Serotonin (MESH:D012701), glucose (MESH:D005947), 8-OHdG (MESH:D000080242), prebiotic (MESH:D056692), hydrogen peroxide (MESH:D006861), fat (MESH:D005223), thiobarbituric acid-reactive substances (MESH:D017392), 8-nitroguanine (MESH:C095838), isoprostanes (MESH:D028421), nitrite (MESH:D009573), carbohydrate (MESH:D002241), nitrosothiols (MESH:D026403), FIP-fve (-), NO (MESH:D009614), pentane (MESH:C033353), metformin (MESH:D008687), dietary fiber (MESH:D004043), cholesterol (MESH:D002784), LPS (MESH:D008070), ROS (MESH:D017382), bile acid (MESH:D001647), lipid (MESH:D008055)
- **Species:** Flammulina velutipes (species) [taxon 38945], Gardnerella vaginalis (species) [taxon 2702], Rattus norvegicus (brown rat, species) [taxon 10116], Bacteroides fragilis (species) [taxon 817], Lactobacillus kefiranofaciens (species) [taxon 267818], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Nicotiana tabacum (American tobacco, species) [taxon 4097], Nippostrongylus brasiliensis (species) [taxon 27835], Leptospira sp. AB (species) [taxon 103236], Trigonella foenum-graecum (fenugreek, species) [taxon 78534], Mus musculus (house mouse, species) [taxon 10090], Akkermansia muciniphila (species) [taxon 239935], Lacticaseibacillus rhamnosus GG (strain) [taxon 568703]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4517425/full.md

## References

115 references — full list in the complete paper: https://tomesphere.com/paper/PMC4517425/full.md

---
Source: https://tomesphere.com/paper/PMC4517425